Joanne E. Filicko-O'hara
Transplant Surgery | Oncology
900 Medical Center Drive
Suite 200
Sewell, NJ 08080
Suite 200
Sewell, NJ 08080
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies - A Prospective Trial.
Journal: Transplantation and cellular therapy
Published: April 22, 2026
The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with Myelofibrosis.
Journal: Hematology/oncology and stem cell therapy
Published: September 03, 2025
The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: June 15, 2025
A Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant, Results of a Prospective Trial.
Journal: Transplantation and cellular therapy
Published: May 13, 2024
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.
Journal: European journal of haematology
Published: October 15, 2023
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
Journal: Transplantation and cellular therapy
Published: June 06, 2022
Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies.
Journal: Bone marrow transplantation
Published: December 16, 2021
The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies.
Journal: Transplantation and cellular therapy
Published: October 09, 2021
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: November 04, 2020
An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation.
Journal: Transplantation and cellular therapy
Published: September 27, 2020
Last Updated: 09/26/2026